Pyrin (MEFV)

Inflammasome sensor protein (mutated in FMF)

Expression
Gain-of-function mutations
Evidence level
established
Targeted by
Colchicine (indirect)

Role in pathogenesis

Pyrin is encoded by the MEFV gene and acts as an intracellular 'guard' sensor for RhoA GTPase activity. In healthy cells, pyrin is kept inactive by PKN1/PKN2-mediated phosphorylation and 14-3-3 protein binding. FMF mutations in the B30.2 domain impair this regulation, allowing pyrin inflammasome assembly upon dephosphorylation alone. This is the root cause of FMF.

Targeting drugs (1)

DrugMechanismResponseLine
ColchicineMicrotubule disruption; reduces leukocyte motility and phagocytosis~95% (attack prevention)1st

Sources (4)

DetailsChae JJ et al. (2011) Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice · ImmunityDOI
DetailsPark YH et al. (2016) Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS · Nat ImmunolDOI
DetailsSchnappauf O et al. (2019) The pyrin inflammasome in health and disease · Front ImmunolDOI
DetailsVan Gorp H et al. (2016) Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation · Proc Natl Acad Sci USADOI